[Protocol for the treatment of chronic viral hepatitis]

Orv Hetil. 2008 Jan 20;149(3):129-35. doi: 10.1556/OH.2008.28287.
[Article in Hungarian]
No abstract available

Publication types

  • Practice Guideline

MeSH terms

  • Adenine / analogs & derivatives
  • Adenine / therapeutic use
  • Algorithms
  • Antiviral Agents / therapeutic use*
  • Clinical Protocols
  • Hepacivirus / genetics
  • Hepacivirus / immunology
  • Hepacivirus / isolation & purification*
  • Hepatitis B virus / genetics
  • Hepatitis B virus / immunology
  • Hepatitis B virus / isolation & purification*
  • Hepatitis B, Chronic / drug therapy*
  • Hepatitis C, Chronic / drug therapy*
  • Humans
  • Interferon alpha-2
  • Interferon-alpha / therapeutic use
  • Interferons / therapeutic use*
  • Lamivudine / therapeutic use
  • Organophosphonates / therapeutic use
  • Polyethylene Glycols / therapeutic use
  • Recombinant Proteins
  • Ribavirin / therapeutic use

Substances

  • Antiviral Agents
  • Interferon alpha-2
  • Interferon-alpha
  • Organophosphonates
  • Recombinant Proteins
  • Lamivudine
  • Polyethylene Glycols
  • Ribavirin
  • Interferons
  • Adenine
  • peginterferon alfa-2a
  • adefovir dipivoxil